Salivary biomarkers associated with myocardial necrosis

Results from an alcohol septal ablation model

Joseph D. Foley, J. Darrell Sneed, Steven R. Steinhubl, Justin R. Kolasa, Jeffrey L. Ebersole, Yushun Lin, Richard J. Kryscio, John T. McDevitt, Charles Campbell, Craig S. Miller

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To determine if salivary biomarkers demonstrate utility for identifying aspects of myocardial necrosis. Methods: Twenty-one patients undergoing alcohol septal ablation (ASA) for treatment of hypertrophic cardiomyopathy provided serum and unstimulated whole saliva at baseline and incremental time points post-ASA. Samples were analyzed for seven biomarkers related to myocardial damage, inflammation, and tissue remodeling using immunosorbent assays. Levels were compared with baseline and levels observed in 97 healthy controls. Results: Biomarkers of myocardial damage and inflammation (ie, troponin I, creatine kinase-MB, myoglobin, C-reactive protein) rose in serum 2- to 812-fold after ASA (P <.01). Significant elevations of 2.0- to 3.5-fold were observed with C-reactive protein and troponin I in saliva (P <.02). Significant correlations between levels in serum and saliva were observed for C-reactive protein, matrix metalloproteinase-9, and myeloperoxidase (P <.001). Conclusions: Select salivary biomarkers reflect changes that occur during, and subsequent to, myocardial necrosis caused by ASA.

Original languageEnglish (US)
Pages (from-to)616-623
Number of pages8
JournalOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Volume114
Issue number5
DOIs
StatePublished - Nov 1 2012
Externally publishedYes

Fingerprint

Necrosis
Biomarkers
Saliva
Alcohols
C-Reactive Protein
Troponin I
Serum
Inflammation
MB Form Creatine Kinase
Immunosorbents
Myoglobin
Hypertrophic Cardiomyopathy
Matrix Metalloproteinase 9
Peroxidase
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oral Surgery
  • Pathology and Forensic Medicine
  • Dentistry (miscellaneous)
  • Radiology Nuclear Medicine and imaging

Cite this

Salivary biomarkers associated with myocardial necrosis : Results from an alcohol septal ablation model. / Foley, Joseph D.; Sneed, J. Darrell; Steinhubl, Steven R.; Kolasa, Justin R.; Ebersole, Jeffrey L.; Lin, Yushun; Kryscio, Richard J.; McDevitt, John T.; Campbell, Charles; Miller, Craig S.

In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Vol. 114, No. 5, 01.11.2012, p. 616-623.

Research output: Contribution to journalArticle

Foley, JD, Sneed, JD, Steinhubl, SR, Kolasa, JR, Ebersole, JL, Lin, Y, Kryscio, RJ, McDevitt, JT, Campbell, C & Miller, CS 2012, 'Salivary biomarkers associated with myocardial necrosis: Results from an alcohol septal ablation model', Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 114, no. 5, pp. 616-623. https://doi.org/10.1016/j.oooo.2012.05.024
Foley, Joseph D. ; Sneed, J. Darrell ; Steinhubl, Steven R. ; Kolasa, Justin R. ; Ebersole, Jeffrey L. ; Lin, Yushun ; Kryscio, Richard J. ; McDevitt, John T. ; Campbell, Charles ; Miller, Craig S. / Salivary biomarkers associated with myocardial necrosis : Results from an alcohol septal ablation model. In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2012 ; Vol. 114, No. 5. pp. 616-623.
@article{eefacd31038f4bc0b0ef6bab2c80b31c,
title = "Salivary biomarkers associated with myocardial necrosis: Results from an alcohol septal ablation model",
abstract = "Objective: To determine if salivary biomarkers demonstrate utility for identifying aspects of myocardial necrosis. Methods: Twenty-one patients undergoing alcohol septal ablation (ASA) for treatment of hypertrophic cardiomyopathy provided serum and unstimulated whole saliva at baseline and incremental time points post-ASA. Samples were analyzed for seven biomarkers related to myocardial damage, inflammation, and tissue remodeling using immunosorbent assays. Levels were compared with baseline and levels observed in 97 healthy controls. Results: Biomarkers of myocardial damage and inflammation (ie, troponin I, creatine kinase-MB, myoglobin, C-reactive protein) rose in serum 2- to 812-fold after ASA (P <.01). Significant elevations of 2.0- to 3.5-fold were observed with C-reactive protein and troponin I in saliva (P <.02). Significant correlations between levels in serum and saliva were observed for C-reactive protein, matrix metalloproteinase-9, and myeloperoxidase (P <.001). Conclusions: Select salivary biomarkers reflect changes that occur during, and subsequent to, myocardial necrosis caused by ASA.",
author = "Foley, {Joseph D.} and Sneed, {J. Darrell} and Steinhubl, {Steven R.} and Kolasa, {Justin R.} and Ebersole, {Jeffrey L.} and Yushun Lin and Kryscio, {Richard J.} and McDevitt, {John T.} and Charles Campbell and Miller, {Craig S.}",
year = "2012",
month = "11",
day = "1",
doi = "10.1016/j.oooo.2012.05.024",
language = "English (US)",
volume = "114",
pages = "616--623",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Salivary biomarkers associated with myocardial necrosis

T2 - Results from an alcohol septal ablation model

AU - Foley, Joseph D.

AU - Sneed, J. Darrell

AU - Steinhubl, Steven R.

AU - Kolasa, Justin R.

AU - Ebersole, Jeffrey L.

AU - Lin, Yushun

AU - Kryscio, Richard J.

AU - McDevitt, John T.

AU - Campbell, Charles

AU - Miller, Craig S.

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Objective: To determine if salivary biomarkers demonstrate utility for identifying aspects of myocardial necrosis. Methods: Twenty-one patients undergoing alcohol septal ablation (ASA) for treatment of hypertrophic cardiomyopathy provided serum and unstimulated whole saliva at baseline and incremental time points post-ASA. Samples were analyzed for seven biomarkers related to myocardial damage, inflammation, and tissue remodeling using immunosorbent assays. Levels were compared with baseline and levels observed in 97 healthy controls. Results: Biomarkers of myocardial damage and inflammation (ie, troponin I, creatine kinase-MB, myoglobin, C-reactive protein) rose in serum 2- to 812-fold after ASA (P <.01). Significant elevations of 2.0- to 3.5-fold were observed with C-reactive protein and troponin I in saliva (P <.02). Significant correlations between levels in serum and saliva were observed for C-reactive protein, matrix metalloproteinase-9, and myeloperoxidase (P <.001). Conclusions: Select salivary biomarkers reflect changes that occur during, and subsequent to, myocardial necrosis caused by ASA.

AB - Objective: To determine if salivary biomarkers demonstrate utility for identifying aspects of myocardial necrosis. Methods: Twenty-one patients undergoing alcohol septal ablation (ASA) for treatment of hypertrophic cardiomyopathy provided serum and unstimulated whole saliva at baseline and incremental time points post-ASA. Samples were analyzed for seven biomarkers related to myocardial damage, inflammation, and tissue remodeling using immunosorbent assays. Levels were compared with baseline and levels observed in 97 healthy controls. Results: Biomarkers of myocardial damage and inflammation (ie, troponin I, creatine kinase-MB, myoglobin, C-reactive protein) rose in serum 2- to 812-fold after ASA (P <.01). Significant elevations of 2.0- to 3.5-fold were observed with C-reactive protein and troponin I in saliva (P <.02). Significant correlations between levels in serum and saliva were observed for C-reactive protein, matrix metalloproteinase-9, and myeloperoxidase (P <.001). Conclusions: Select salivary biomarkers reflect changes that occur during, and subsequent to, myocardial necrosis caused by ASA.

UR - http://www.scopus.com/inward/record.url?scp=84867678149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867678149&partnerID=8YFLogxK

U2 - 10.1016/j.oooo.2012.05.024

DO - 10.1016/j.oooo.2012.05.024

M3 - Article

VL - 114

SP - 616

EP - 623

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 5

ER -